Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma

NCT01107665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Stage III Melanoma
Stage IV Melanoma
Unresectable Melanoma

Interventions

DRUG: Pazopanib and Paclitaxel

Sponsor

University of California, Irvine

Collaborators

[object Object]